Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | TYK2 | P29597 | 2/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20031135 | 0.74 | CCR1 (0.54) | PPARATYK2AOC3 | |
| SCHEMBL20969942 | 0.72 | PPARA (0.40) | PPARAGABRG2GABRB3GABRA5AOC3 | |
| SCHEMBL12404673 | 0.70 | PPARA (0.46) | PPARAAOC3 | |
| SCHEMBL31503961 | 0.70 | APLNR (0.44) | — | |
| SCHEMBL13052072 | 0.70 | APLNR (0.44) | — | |
| SCHEMBL12131263 | 0.68 | KDM4E (0.52) | PPARA | |
| SCHEMBL16341540 | 0.67 | ALDH1A1 (0.47) | — | |
| SCHEMBL24054376 | 0.66 | PPARA (0.36) | PPARAAOC3HCRTR1HCRTR2 | |
| SCHEMBL22053003 | 0.64 | PPARA (0.40) | PPARATYK2GABRG2GABRB3GABRA5 | |
| SCHEMBL822577 | 0.64 | NPC1 (0.47) | PPARAAOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180093951-A1 | PESTICIDALLY ACTIVE CARBAMOYLATED AND THIOCARBAMOYLATED OXIME DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2018-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180093951-A1 | PESTICIDALLY ACTIVE CARBAMOYLATED AND THIOCARBAMOYLATED OXIME DERIVATIVES | ACHE, DDT, BCHE | PPARA 1409/4885TYK2 2081/4885GABRG2 2321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.